Literature DB >> 14664809

Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems.

Juha Laurén1, Matti S Airaksinen, Mart Saarma, Tõnis Timmusk.   

Abstract

The regenerative capacity of the adult mammalian central nervous system is restricted by the myelinating oligodendrocytes that form a nonpermissive environment for axonal growth. Currently only the Nogo receptor (NgR), in complex with p75(NTR) neurotrophin receptor is known to be involved in this inhibitory signalling in neurons. NgR is a common receptor for the three inhibitory myelin proteins Nogo-A, OMgp, and MAG. Here we describe two novel Nogo receptor gene homologs named NGRL2 and NGRL3 from human and mouse that, like NGR, encode putative leucine-rich repeat containing GPI-anchored proteins. We show by in situ hybridisation and by RT-PCR that NGRL mRNAs are predominantly expressed in the neurons of the embryonic and adult central and peripheral nervous systems, and that they together with NGR possess distinct and partially nonoverlapping expression patterns. We also show that all four members of the reticulon family, including Nogo-A, are widely expressed in the nervous system, and therefore are possible ligands for the NgRLs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14664809     DOI: 10.1016/s1044-7431(03)00199-4

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  37 in total

Review 1.  New Insights into the Roles of Nogo-A in CNS Biology and Diseases.

Authors:  Yun-Peng Sui; Xiao-Xi Zhang; Jun-Lin Lu; Feng Sui
Journal:  Neurochem Res       Date:  2015-08-13       Impact factor: 3.996

2.  The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.

Authors:  Karthik Venkatesh; Onanong Chivatakarn; Hakjoo Lee; Pushkar S Joshi; David B Kantor; Barbara A Newman; Rose Mage; Christoph Rader; Roman J Giger
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

Review 3.  Targeting myelin to optimize plasticity of spared spinal axons.

Authors:  Angela L M Scott; Leanne M Ramer; Lesley J J Soril; Jacek M Kwiecien; Matt S Ramer
Journal:  Mol Neurobiol       Date:  2006-04       Impact factor: 5.590

Review 4.  Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

Review 5.  Glial inhibition of CNS axon regeneration.

Authors:  Glenn Yiu; Zhigang He
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

6.  Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector.

Authors:  Thomas Hofer; Wisit Tangkeangsirisin; Michael G Kennedy; Rose G Mage; Stephen J Raiker; Karthik Venkatesh; Hakjoo Lee; Roman J Giger; Christoph Rader
Journal:  J Immunol Methods       Date:  2006-11-07       Impact factor: 2.303

Review 7.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

8.  Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition.

Authors:  Xiangdong Zhou; Xiangyou Hu; Wanxia He; Xiaoying Tang; Qi Shi; Zhuohua Zhang; Riqiang Yan
Journal:  FASEB J       Date:  2011-06-13       Impact factor: 5.191

9.  Increased hippocampal NgR1 signaling machinery in aged rats with deficits of spatial cognition.

Authors:  Heather D VanGuilder Starkey; William E Sonntag; Willard M Freeman
Journal:  Eur J Neurosci       Date:  2013-02-26       Impact factor: 3.386

Review 10.  Roles of channels and receptors in the growth cone during PNS axonal regeneration.

Authors:  Sangwoo Shim; Guo-li Ming
Journal:  Exp Neurol       Date:  2009-10-13       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.